EMORY UNIVERSITY
- Country
- đşđ¸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
- Conditions
- Interventions
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Emory University
- Registration Number
- NCT05514912
Investigational Imaging Technique During Brain Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Emory University
- Target Recruit Count
- 24
- Registration Number
- NCT05513859
- Locations
- đşđ¸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
- Conditions
- Interventions
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Emory University
- Target Recruit Count
- 11
- Registration Number
- NCT05506982
- Locations
- đşđ¸
Brain Health Center at Executive Park, Atlanta, Georgia, United States
đşđ¸Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 1000
- Registration Number
- NCT05502107
- Locations
- đşđ¸
University of Iowa, Iowa City, Iowa, United States
đşđ¸Washington University, Saint Louis, Missouri, United States
đşđ¸Emory University Hospital, Atlanta, Georgia, United States
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-08-09
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 15
- Registration Number
- NCT05493566
- Locations
- đşđ¸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy
- Conditions
- Interventions
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 30
- Registration Number
- NCT05488145
- Locations
- đşđ¸
Emory University Hospital Midtown, Atlanta, Georgia, United States
đşđ¸Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
đşđ¸Emory Johns Creek Hospital, Johns Creek, Georgia, United States
Mobile Health Intervention to Increase HIV Testing and Linkage to Care
- Conditions
- Interventions
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Emory University
- Target Recruit Count
- 1800
- Registration Number
- NCT05484895
- Locations
- đ¨đł
Wuhan Centers for Disease Control and Prevention, Wuhan, Hubei, China
đ¨đłSuzhou Centers for Disease Control and Prevention, Suzhou, Jiangsu, China
đ¨đłChengdu Tongle Health Counselling Service Center, Chengdu, Sichuan, China
Ventricular Tachycardia Mechanisms
- Conditions
- Interventions
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 10
- Registration Number
- NCT05478213
- Locations
- đşđ¸
Emory University Hospital Midtown, Atlanta, Georgia, United States
đşđ¸Emory Clinic, Atlanta, Georgia, United States
đşđ¸Emory University Hospital, Atlanta, Georgia, United States
Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
- Conditions
- Interventions
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 42
- Registration Number
- NCT05466539
- Locations
- đşđ¸
Emory Sports Medicine-Dunwoody, Atlanta, Georgia, United States
đşđ¸Emory Hawks Sports Medicine Center, Brookhaven, Georgia, United States
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Emory University
- Target Recruit Count
- 40
- Registration Number
- NCT05464810
- Locations
- đşđ¸
Emory University Hospital Midtown, Atlanta, Georgia, United States
đşđ¸Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
đşđ¸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States